ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 4 filers reported holding ALKERMES PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,047 | -33.5% | 680 | -25.7% | 0.00% | – |
| Q2 2023 | $28,640 | +49.4% | 915 | +34.6% | 0.00% | – |
| Q1 2023 | $19,169 | -27.4% | 680 | -32.7% | 0.00% | – |
| Q4 2022 | $26,391 | +20.0% | 1,010 | 0.0% | 0.00% | – |
| Q3 2022 | $22,000 | +633.3% | 1,010 | +910.0% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | +50.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 100 | -33.3% | 0.00% | – |
| Q3 2020 | $2,000 | -77.8% | 150 | -68.7% | 0.00% | – |
| Q2 2020 | $9,000 | -18.2% | 479 | -37.1% | 0.00% | – |
| Q1 2020 | $11,000 | -77.6% | 762 | -68.1% | 0.00% | – |
| Q4 2019 | $49,000 | +14.0% | 2,389 | +8.3% | 0.00% | – |
| Q3 2019 | $43,000 | +16.2% | 2,206 | +33.9% | 0.00% | – |
| Q2 2019 | $37,000 | -45.6% | 1,648 | -11.9% | 0.00% | – |
| Q1 2019 | $68,000 | +23.6% | 1,870 | 0.0% | 0.00% | – |
| Q4 2018 | $55,000 | -20.3% | 1,870 | +15.1% | 0.00% | – |
| Q3 2018 | $69,000 | +23.2% | 1,625 | +20.3% | 0.00% | – |
| Q2 2018 | $56,000 | -12.5% | 1,351 | +21.5% | 0.00% | – |
| Q1 2018 | $64,000 | +106.5% | 1,112 | +95.8% | 0.00% | – |
| Q4 2017 | $31,000 | +106.7% | 568 | +89.3% | 0.00% | – |
| Q3 2017 | $15,000 | -16.7% | 300 | -4.2% | 0.00% | – |
| Q2 2017 | $18,000 | -5.3% | 313 | +0.6% | 0.00% | – |
| Q1 2017 | $19,000 | -9.5% | 311 | -16.4% | 0.00% | – |
| Q4 2016 | $21,000 | +110.0% | 372 | +65.3% | 0.00% | – |
| Q2 2016 | $10,000 | +25.0% | 225 | 0.0% | 0.00% | – |
| Q1 2016 | $8,000 | -50.0% | 225 | +12.5% | 0.00% | – |
| Q4 2015 | $16,000 | +1500.0% | 200 | +1076.5% | 0.00% | – |
| Q3 2015 | $1,000 | -75.0% | 17 | -79.8% | 0.00% | – |
| Q3 2014 | $4,000 | 0.0% | 84 | 0.0% | 0.00% | – |
| Q2 2014 | $4,000 | 0.0% | 84 | 0.0% | 0.00% | – |
| Q1 2014 | $4,000 | +33.3% | 84 | 0.0% | 0.00% | – |
| Q4 2013 | $3,000 | 0.0% | 84 | 0.0% | 0.00% | – |
| Q3 2013 | $3,000 | – | 84 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |